CDK5 and Alzheimer disease: In a previous study, we have demonstrated that AAV9 mediated CIP inhibits the activity of Cdk5/p25 complex indicating by reduction of phosphorylated tau and Aβ aggregation in AD mouse model (He et al., 2017).